Quantum BioPharma is trading at $3.55 (+10.84%), with broader biotech sentiment supported by argenx’s $2.2 billion Forte Biosciences acquisition.
- No verified company-specific announcement or earnings release was identified for August 7, 2026.
- The stock is continuing its August 6, 2026 gain of 11.38% and August 3, 2026 advance of 5.54%.
- Quantum’s August 3 MS-study update appears to be supporting background sentiment rather than a new catalyst.